| Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. | |
| | |
MedLine Citation:
|
PMID: 12075207 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been identified in a variety of carcinomas, but there are few studies concerning their presence in oral cancers. The objective of this study was to determine whether FGF-1, FGF-2, and high affinity receptors FGFR2 and FGFR3 are present in the pathogenesis of oral epithelial dysplasias and oral squamous cell carcinoma. STUDY DESIGN: Sections from formalin-fixed, paraffin-embedded samples of oral normal mucosa (n = 14), epithelial dysplasia (n = 20), carcinoma in situ (n = 10), and squamous cell carcinoma (n = 12) were tested for cytoplasmic staining by standard in situ immunohistochemistry with antibodies for FGF-1, FGF-2, FGFR2, and FGFR3. RESULTS: Staining for FGF-1 is decreased or lost in the development of epithelial dysplasia and carcinoma. Staining for FGF-2 showed increased intensity (although not statistically significant) in oral epithelial dysplasias and squamous cell carcinomas and showed a significant increased expression in the upper layers of dysplasias and stratum spinosum-like cells in squamous cell carcinomas. Staining for FGFR2 showed a statistically significant increase in intensity in all layers of epithelial dysplasias and squamous cell carcinomas. Staining for FGFR3 was found in the upper stratum spinosum cells of normal and dysplastic epithelium and well-differentiated squamous cells in squamous cell carcinomas, with a statistically significant increase in staining intensity in dysplastic and carcinomatous tissues. CONCLUSIONS: The loss of FGF-1 is consistent with loss of differentiation in dysplasias and some squamous cell carcinomas. Changes in the localization of FGF-2 and FGFR2 into upper epithelial layers with increasing dysplasia suggest increased mitotic potential of high level cells. The co-localization of FGF-2 and its high affinity receptors in neoplastic tissues suggests an autocrine mechanism of influence on carcinogenesis. |
| | |
Authors:
|
Candice Wakulich; Linda Jackson-Boeters; Tom D Daley; George P Wysocki |
Related Documents
:
|
10737717 - Induction of s100a4 gene expression inhibits in vitro invasiveness of human squamous ce... 17878747 - Telomere metabolism and diagnostic demonstration of telomere measurement in the human e... 2460817 - Spindle cell squamous carcinoma of the tongue in the first decade of life. 12451567 - Atrophic vaginitis versus invasive squamous cell carcinoma on thinprep cytology: can th... 22559937 - New insights into the mechanism of lens development using zebra fish. 23296277 - Signalling pathways that inhibit the capacity of precursor cells for myelin repair. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics Volume: 93 ISSN: 1079-2104 ISO Abbreviation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Publication Date: 2002 May |
Date Detail:
|
Created Date: 2002-06-20 Completed Date: 2002-09-03 Revised Date: 2012-06-05 |
Medline Journal Info:
|
Nlm Unique ID: 9508562 Medline TA: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Country: United States |
Other Details:
|
Languages: eng Pagination: 573-9 Citation Subset: D; IM |
Affiliation:
|
University of Western Ontario, London, Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies
/
diagnostic use Autocrine Communication Biological Markers / analysis Carcinoma in Situ / pathology Carcinoma, Squamous Cell / pathology* Cell Differentiation Coloring Agents / diagnostic use Cytoplasm / ultrastructure Epithelium / pathology Fibroblast Growth Factor 1 / analysis* Fibroblast Growth Factor 2 / analysis* Humans Immunohistochemistry Matched-Pair Analysis Mitosis Mouth Mucosa / cytology* Mouth Neoplasms / pathology* Protein-Tyrosine Kinases* Receptor Protein-Tyrosine Kinases / analysis* Receptor, Fibroblast Growth Factor, Type 2 Receptor, Fibroblast Growth Factor, Type 3 Receptors, Fibroblast Growth Factor / analysis* Statistics, Nonparametric Tumor Markers, Biological / analysis |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies; 0/Biological Markers; 0/Coloring Agents; 0/Receptors, Fibroblast Growth Factor; 0/Tumor Markers, Biological; 103107-01-3/Fibroblast Growth Factor 2; 104781-85-3/Fibroblast Growth Factor 1; EC 2.7.10.1/FGFR2 protein, human; EC 2.7.10.1/FGFR3 protein, human; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 2; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 3 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Oral manifestations of patients with Marfan syndrome: a case-control study.
Next Document: Rhabdomyosarcoma of the oral and maxillofacial region in Jordanians: a retrospective analysis.